- Filed
- Dec 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Nov 30, 2025 | 162.58M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 4.66M sh |
| Operating Cash Flow restated | FY 2024 · Dec 31, 2023 | −$14.76M |
| Long Term Debt | FY 2024 · Dec 31, 2023 | $8.9M |
| Cash And Equivalents restated | FY 2024 · Dec 31, 2023 | $2.69M |
| Current Liabilities restated | FY 2024 · Dec 31, 2023 | $9.39M |
| Total Liabilities restated | FY 2024 · Dec 31, 2023 | $18.29M |
| Current Assets restated | FY 2024 · Dec 31, 2023 | $5.59M |
| Total Assets restated | FY 2024 · Dec 31, 2023 | $8.07M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$5.82 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$5.82 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $7.41M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $5.92M |
| Net Income restated | FY 2024 · Dec 31, 2023 | −$29.73M |
| Operating Income restated | FY 2024 · Dec 31, 2023 | −$18.11M |
| Gross Profit | FY 2024 · Dec 31, 2023 | $1.1M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $4.58M |
| Revenue | FY 2024 · Dec 31, 2023 | $5.68M |
| Stockholders Equity restated | FY 2024 · Dec 31, 2022 | −$57.08M |